News & Perspective

Oct 14, 2010

Oct 14, 2010

SIGA gets federal contract to produce smallpox antiviral

(CIDRAP News) – In a move to allow the United States to stockpile its first specialized treatment for smallpox bioterror attacks and related infections, SIGA Technologies announced yesterday that it will receive a federal contract to deliver 1.7 million courses of a new antiviral medication.

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»


Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


  Become an underwriter»